FDA Approves Juluca, a Novel 2-Drug Regimen for HIV-1 Infection In November, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Juluca (dolutegravir and rilpivirine), a single-tablet, two-drug regimen of dolutegravir…Original Article
You may also like
Aesthetic Surgical Rep Austin/San Antonio- Allergan...
Territory Sales Representative
Biopsy Sales Specialist – Miami, FL
Clinical Specialist
Medical Device Sales – Modesto, CA
Associate Territory Manager, Neurovascular –...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.